Lipocalin 2 modulates the cellular response to amyloid beta

Area of Science:

• Neuroscience
• Biochemistry
• Cell Biology

Background:

• Amyloid beta (Aβ) peptides are central to Alzheimer's disease (AD) pathogenesis.
• Iron and related proteins modulate Aβ production and aggregation.
• Lipocalin 2 (LCN2) is an acute-phase protein involved in iron homeostasis.

Purpose of the Study:

• Investigate the role of LCN2 in the cellular response to Aβ1-42.
• Determine the impact of LCN2 on astrocyte survival and inflammation under Aβ1-42 stimulation.

Main Methods:

• Stimulation of primary cell cultures with Aβ1-42.
• Analysis of LCN2 production in response to Aβ1-42.
• Assessment of astrocyte viability, apoptosis (Bim gene expression), and inflammatory markers.
• Comparison between wild-type and Lcn2-deficient astrocytes.

Main Results:

• Aβ1-42 significantly increases LCN2 production in choroid plexus epithelial cells and astrocytes.
• Aβ1-42 reduces dehydrogenase activity and survival in wild-type astrocytes.
• Astrocytes lacking LCN2 expression are protected from Aβ1-42-induced toxicity.
• This protection is associated with reduced Bim expression and inflammatory response.

Conclusions:

• LCN2 is a key mediator of Aβ1-42 toxicity to astrocytes.
• The Aβ-induced LCN2 production triggers apoptosis and inflammation in astrocytes.
• Targeting LCN2 may offer a novel therapeutic strategy for Alzheimer's disease.